149 related articles for article (PubMed ID: 6302694)
1. Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment.
Arnheiter H; Ohno M; Smith M; Gutte B; Zoon KC
Proc Natl Acad Sci U S A; 1983 May; 80(9):2539-43. PubMed ID: 6302694
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of human alpha interferon to a high affinity cell surface binding site on bovine kidney cells.
Zoon K; Zur Nedden D; Arnheiter H
J Biol Chem; 1982 May; 257(9):4695-7. PubMed ID: 6175643
[TBL] [Abstract][Full Text] [Related]
3. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
[TBL] [Abstract][Full Text] [Related]
4. Human interferon alpha enters cells by receptor-mediated endocytosis.
Zoon KC; Arnheiter H; Zur Nedden D; Fitzgerald DJ; Willingham MC
Virology; 1983 Oct; 130(1):195-203. PubMed ID: 6314645
[TBL] [Abstract][Full Text] [Related]
5. A crystalline synthetic peptide representing the epitope of a monoclonal antibody raised against synthetic interferon-alpha 1 fragment 111-166.
Aguet M; Salgam P; Gutte B; Arnheiter H
Eur J Biochem; 1985 Feb; 146(3):689-91. PubMed ID: 2578959
[TBL] [Abstract][Full Text] [Related]
6. Different binding of human interferon alpha 1 and alpha 2 to common receptors on human and bovine cells. Studies with recombination interferons produced in Escherichia coli.
Yonehara S; Yonehara-Takahashi M; Ishii A; Nagata S
J Biol Chem; 1983 Aug; 258(15):9046-9. PubMed ID: 6307990
[TBL] [Abstract][Full Text] [Related]
7. Epitopes of human interferon-alpha defined by the reaction of monoclonal antibodies with alpha interferons and interferon analogues.
Taylor-Papadimitriou J; Shearer M; Griffin D
J Immunol; 1987 Nov; 139(10):3375-81. PubMed ID: 2445813
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
Cutrone EC; Langer JA
J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
[TBL] [Abstract][Full Text] [Related]
9. Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in function.
Magazine HI; Carter JM; Russell JK; Torres BA; Dunn BM; Johnson HM
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1237-41. PubMed ID: 2448795
[TBL] [Abstract][Full Text] [Related]
10. Interferon-tau and interferon-alpha interact with the same receptors in bovine endometrium. Use of a readily iodinatable form of recombinant interferon-tau for binding studies.
Li J; Roberts RM
J Biol Chem; 1994 May; 269(18):13544-50. PubMed ID: 8175789
[TBL] [Abstract][Full Text] [Related]
11. Type I and Type II interferon receptors.
Orchansky P; Novick D; Fischer DG; Rubinstein M
J Interferon Res; 1984; 4(2):275-82. PubMed ID: 6086780
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding.
Eid P; Tovey MG
J Interferon Cytokine Res; 1995 Mar; 15(3):205-11. PubMed ID: 7584665
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human type I interferon receptor by ligand blotting.
Schwabe M; Princler GL; Faltynek CR
Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
16. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
17. Reduced receptor binding by a human interferon-gamma fragment lacking 11 carboxyl-terminal amino acids.
Leinikki PO; Calderon J; Luquette MH; Schreiber RD
J Immunol; 1987 Nov; 139(10):3360-6. PubMed ID: 2960733
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human interferon-alpha receptor expression by human interferon-gamma.
Hannigan GE; Fish EN; Williams BR
J Biol Chem; 1984 Jul; 259(13):8084-6. PubMed ID: 6330099
[TBL] [Abstract][Full Text] [Related]
19. Specific residues within an amino-terminal domain of 35 residues of interferon alpha are responsible for recognition of the human interferon alpha cell receptor and for triggering biological effects.
Shafferman A; Velan B; Cohen S; Leitner M; Grosfeld H
J Biol Chem; 1987 May; 262(13):6227-37. PubMed ID: 2952649
[TBL] [Abstract][Full Text] [Related]
20. Internalization and degradation of human alpha-A interferon bound to bovine MDBK cells: regulation of the decay and resynthesis of receptors.
Branca AA; D'Alessandro SB; Baglioni C
J Interferon Res; 1983; 3(4):465-71. PubMed ID: 6323593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
